Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer.
about
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Loss of ataxia-telangiectasia- ...... chemotherapy in breast cancer.
@en
type
label
Loss of ataxia-telangiectasia- ...... chemotherapy in breast cancer.
@en
prefLabel
Loss of ataxia-telangiectasia- ...... chemotherapy in breast cancer.
@en
P2093
P2860
P50
P1476
Loss of ataxia-telangiectasia- ...... chemotherapy in breast cancer.
@en
P2093
Do-Youn Oh
Han Suk Ryu
Hyojin Kim
In Ae Park
Kyung-Hun Lee
Sae-Won Han
Seock-Ah Im
Tae-Yong Kim
Wonshik Han
P2860
P2888
P304
P356
10.1007/S10549-016-3869-X
P407
P577
2016-06-21T00:00:00Z
P6179
1024833868